Leucine-rich alpha-2 glycoprotein as a blood biomarker in Inflammatory bowel disease: clinical implications and future perspectives
{{output}}
Introduction: Reliable biomarkers for monitoring inflammatory bowel disease (IBD) remain an unmet clinical need, particularly in patients receiving biologic therapies where C-reactive protein (CRP) responses may be attenuated. Le... ...
